Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 11th March 2026
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

BVA Live 2026 line-up revealed
"BVA Live is always a great opportunity to meet with colleagues from across the profession" - Dr Rob WIlliams.

Delegates can expect sessions on the CMA investigation and ethical decision-making.

The full line-up of speakers and panellists for BVA Live 2026 has been revealed.

Due to take place at the NEC in Birmingham (11-12 June), the event promises 17 hours of stimulating CPD, networking opportunities, and a chance to learn about new developments in the veterinary sector.

Among the highlights include a session on managing complaints in the wake of the CMA investigation. BVA President Rob Williams, Jennie Jones, Head of the Veterinary Client Mediation Service, and Gavin Durston, director of Thrums Vets, will explore what veterinary teams may need to understand about CMA expectations and how to handle complaints effectively and transparently.

The programme also includes a debate on ethical decision-making. BVA Senior Vice President Elizabeth Mullineaux will lead a panel discussion on where ethical responsibility sits, how it differs from welfare assessment and what practical frameworks can help vets make defensible, compassionate decisions in real-world cases. 

Highlights from the clinical streams include euthanasia in small mammals, birds and reptiles; anaesthesia in comorbid patients; updates in ocular pharmacology; optimising hospital care for long-term patients; and managing anxiety in “pandemic puppies”.   

Also returning for 2026 is the BVA Interactive Zone, where BVA President Rob Williams, Senior Vice President Elizabeth Mullineaux, and Junior Vice President Gwen Rees will lead debates on over-treatment, managing and improving a toxic workplace and contextualised care.  

BVA president Dr Rob Williams said: “As the profession emerges from the CMA investigation, BVA Live will be one of the first opportunities for vet teams to come together to access practical CPD to move forwards and comply with the CMA remedies. This year’s programme dives into a number of areas where we expect the CMA will be looking for change, particularly when it comes to handling complaints and improving transparency.

“BVA Live is always a great opportunity to meet with colleagues from across the profession, to share your views and benefit from the experiences of other veterinary professionals, and this year we’re expecting even more people than ever. We look forward to seeing you there.” 

The full programme and information on how to attend are available on the BVA Live website.

© wellphoto/Shutterstock.com

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.